FindTrial
Sign In

Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]

BIOLOGICAL3 trials

Sponsors

Genzyme, a Sanofi Company

Conditions

Acute Lymphocytic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Acute Renal Allograft RejectionCadaveric Donor Renal TransplantationGraft RejectionGraft vs. Host Disease (GvHD)Induction TherapyRenal Transplantation

Phase 2

A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection
CompletedNCT00089947
Genzyme, a Sanofi CompanyGraft Rejection, Renal Transplantation
Start: 2003-06-30End: 2005-12-31Target: 150Updated: 2015-03-18
An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.
CompletedNCT00235300
Genzyme, a Sanofi CompanyAcute Renal Allograft Rejection, Cadaveric Donor Renal Transplantation, Induction Therapy
Start: 2000-05-31End: 2005-06-30Updated: 2015-03-18

Unknown Phase

Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant
CompletedNCT00088543
Genzyme, a Sanofi CompanyAcute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Graft vs. Host Disease (GvHD)
Start: 2004-03-31End: 2006-04-30Updated: 2015-03-18

Related Papers

Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.
2015-08-1924 citations
Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
2006-11-01494 citations